Peginterferon Alfa-2a: A review of approved and investigational usesMATTHEWS, S. James; MCCOY, Christopher.Clinical therapeutics. 2004, Vol 26, Num 7, pp 991-1025, issn 0149-2918, 35 p.Article

Pegylated interferon-α2a kinetics during experimental haemodialysis: impact of permeability and pore size of dialysersBARRIL, G; QUIROGA, J. A; SANZ, P et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 1, pp 37-44, issn 0269-2813, 8 p.Article

Randomized dose-escalation study evaluating peginterferon Alfa-2a in patients with metastatic malignant melanomaDUMMER, Reinhard; GARBE, Claus; THOMPSON, John A et al.Journal of clinical oncology. 2006, Vol 24, Num 7, pp 1188-1194, issn 0732-183X, 7 p.Article

Reduction in p48-ISGFγ levels confers resistance to Interferon-α_2a in MHCC97 cellsWU, Wei-Zhong; SUN, Hui-Chuan; GAO, Yan-Qin et al.Oncology. 2004, Vol 67, Num 5-6, pp 428-440, issn 0030-2414, 13 p.Article

Hepatitis B Virus Surface Antigen Levels : A Guide to Sustained Response to peginterferon alfa-2a in HBeAg-Negative Chronic Hepatitis BROSSANA BRUNETTE, Maurizia; MORICONI, Francesco; WOLF, Eva et al.Hepatology (Baltimore, Md.). 2009, Vol 49, Num 4, pp 1141-1150, issn 0270-9139, 10 p.Article

The relationship between IL-28B polymorphisms and the response to peginterferon alfa-2a monotherapy in anti-HBe-positive patients with chronic HBV infectionDOMAGALSKI, K; PAWLOWSKA, M; ZALESNA, A et al.European journal of clinical microbiology & infectious diseases (Print). 2014, Vol 33, Num 11, pp 2025-2033, issn 0934-9723, 9 p.Article

Host Gene Expression Changes Correlating With Anti-HIV-1 Effects in Human Subjects After Treatment With Peginterferon Alfa-2aHUBBARD, Jonathan J; GREENWELL-WILD, Teresa; BARRETT, Lisa et al.The Journal of infectious diseases. 2012, Vol 205, Num 9, pp 1443-1447, issn 0022-1899, 5 p.Article

Identifying Hepatitis C Virus Genotype 2/3 Patients Who Can Receive a 16-Week Abbreviated Course of Peginterferon Alfa-2a (40KD) Plus RibavirinDIAGO, Moises; SHIFFMAN, Mitchell L; BRONOWICKI, Jean-Pierre et al.Hepatology (Baltimore, Md.). 2010, Vol 51, Num 6, pp 1897-1903, issn 0270-9139, 7 p.Article

Peginterferon α-2a Plus Ribavirin in Latino and Non-Latino Whites With HCV Genotype 1: Histologic Outcomes and Tolerability From the LATI NO StudyBALART, Luis A; LISKER-MELMAN, Mauricio; HAMZEH, Fayez M et al.The American journal of gastroenterology. 2010, Vol 105, Num 10, pp 2177-2185, issn 0002-9270, 9 p.Article

Efficacy and Safety of Peginterferon Alfa-2a/Ribavirin in Methadone Maintenance Patients : Randomized Comparison of Direct Observed Therapy and Self-AdministrationBONKOVSKY, Herbert L; TICE, Alan D; YAPP, Rockford G et al.The American journal of gastroenterology. 2008, Vol 103, Num 11, pp 2757-2765, issn 0002-9270, 9 p.Article

Peginterferon Alfa-2a for AIDS-Associated Kaposi Sarcoma: Experience With 10 PatientsROKX, Casper; VAN DER ENDE, Marchina E; VERBON, Annelies et al.Clinical infectious diseases. 2013, Vol 57, Num 10, pp 1497-1499, issn 1058-4838, 3 p.Article

ETUDE RMP DES PRODUITS DE CONDENSATION PHOTOCHIMIQUE DES BUTYL-9 ET DIBUTYL-9,10 PHENANTHRENES AVEC L'ANHYDRIDE MALEIQUETSITSISHVILI VG; LEKVEISHVILI EH G.1974; SOOBSHCH. AKAD. NAUK GRUZ. S.S.R.; S.S.S.R.; DA. 1974; VOL. 73; NO 1; PP. 73-76; ABS. GEORGIEN ANGL.; BIBL. 5 REF.Article

Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis CPRATI, Daniele; SHIFFMAN, Mitchell L; ZEUZEM, Stefan et al.Journal of hepatology. 2006, Vol 44, Num 4, pp 679-685, issn 0168-8278, 7 p.Article

Early Serum HBsAg Drop : A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative PatientsMOUCARI, Rami; MACKIEWICZ, Vincent; VALLA, Dominique et al.Hepatology (Baltimore, Md.). 2009, Vol 49, Num 4, pp 1151-1157, issn 0270-9139, 7 p.Article

IL-22 : A critical mediator in mucosal host defenseAUJLA, S. J; KOLLS, J. K.Journal of molecular medicine (Berlin. Print). 2009, Vol 87, Num 5, pp 451-454, issn 0946-2716, 4 p.Article

Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patientsGOWIN, Krisstina; THAPALIYA, Prakash; CAMORIANO, John et al.Haematologica (Roma). 2012, Vol 97, Num 10, pp 1570-1573, issn 0390-6078, 4 p.Article

Impaired dimerization of von willebrand factor subunit due to mutation A280 ID in the CK domain results in a recessive type 2A subtype IID von willebrand diseaseHOMMAIS, Antoine; STEPANIAN, Alain; FRESSINAUD, Edith et al.Thrombosis and haemostasis. 2006, Vol 95, Num 5, pp 776-781, issn 0340-6245, 6 p.Article

Definition of rapid virologic response with a highly sensitive real-time PCR-based HCV RNA assay in peginterferon alfa-2a plus ribavirin response-guided therapySARRAZIN, Christoph; SHIFFMAN, Mitchell L; HADZIYANNIS, Stephanos J et al.Journal of hepatology. 2010, Vol 52, Num 6, pp 832-838, issn 0168-8278, 7 p.Article

Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Hepatitis C Patients with Advanced Fibrosis and CirrhosisBRUNO, Savino; SHIFFMAN, Mitchell L; ROBERTS, Stuart K et al.Hepatology (Baltimore, Md.). 2010, Vol 51, Num 2, pp 388-397, issn 0270-9139, 10 p.Article

HBsAg Profiles in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C VirusesYU, Ming-Lung; LEE, Chuan-Mo; WANG, Jin-Houng et al.The Journal of infectious diseases. 2010, Vol 202, Num 1, pp 86-92, issn 0022-1899, 7 p.Article

Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis CRODRIGUEZ-TORRES, Maribel; JEFFERS, Lennoxj; SHEIKH, Muhammad Y et al.The New England journal of medicine. 2009, Vol 360, Num 3, pp 257-267, issn 0028-4793, 11 p.Article

Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosisEVERSON, G. T; BALART, L; LEE, S. S et al.Alimentary pharmacology & therapeutics. 2008, Vol 27, Num 7, pp 542-551, issn 0269-2813, 10 p.Article

R1626 Plus Peginterferon Alfa-2a Provides Potent Suppression of Hepatitis C Virus RNA and Significant Antiviral Synergy in Combination with RibavirinPOCKROS, Paul J; NELSON, David; NAJERA, Isabel et al.Hepatology (Baltimore, Md.). 2008, Vol 48, Num 2, pp 385-397, issn 0270-9139, 13 p.Article

Peginterferon alfa-2a does not alter the pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapySULKOWSKI, Mark; WRIGHT, Teresa; ROSSI, Stephen et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 3, pp 214-224, issn 0009-9236, 11 p.Article

Welche Kältemittel in der Zukunft? = Which refrigerant in the future?DOÊRING, R.Die Kälte und Klimatechnik. 1990, Vol 43, Num 9, pp 472-482, issn 0343-2246, 6 p.Article